Policy Briefs – COVID-19

Home
-
Policy Briefs

Policy Briefs

COVID Briefs - 2022

High prevalence of antibodies against COVID-19 within the general population

Modelling the Cost-Effectiveness of COVID-19 Vaccination Strategies in Kenya

The mortality impact of COVID-19 from population-based surveillance in Kilifi Coun

Private pharmacies’ contribution to the COVID-19 response how can it be maximized

COVID Related Briefs - 2021

SARS CoV2 antibody prevalence among blood donors in Kenya

Understanding the mortality impact of COVID-19 from a population-based survey in Kilifi County

Modelling forecasts of a fourth wave of COVID-19 in Kenya: when, where and how big?

Tackling pandemics quality of care, health workers

Explaining the Three Waves of the COVID-19 Transmission in Kenya using a Mathematical Model (004)

Sero-prevalence of SARS-CoV-2 among truck drivers in Kenya

Projections of COVID-19 Cases and Deaths Following Schools Reopening

Emergence of new SARS-CoV-2 Variants of Concern

Modelling the Impact of COVID-19 Vaccination Scenarios in Kenya

COVID-19 Sequencing Briefs -2021

The Delta VOC is the dominant SARS-CoV-2 variant in Kenya

The Delta VOC is the dominant SARS-CoV-2 variant in Kenya

Genomic surveillance detects local transmission of the global variants of concern in nine counties in Kenya

Genomic surveillance of SARS-CoV-2 Variants of Concern on the Kenyan Coast 25th June 2021 POLICY

Genomic surveillance indicates dominance of local transmission of the global variants of concern in Kilifi, Taita Taveta and Mandera counties in Kenya

The Alpha (B.1.1.7) variant of concern continues to predominate SARS-CoV-2 infections in Kenya

The Alpha (B.1.1.7) variant of concern continues predominating SARS-CoV-2 infections on the Kenyan Coast

Detection of SARS-CoV-2 variants B.1.1.7, B.1.351 and B.1.617.2 in samples collected from Nairobi and Coastal Kenya

Detection of SARS-CoV-2 Variant of Concern (B.1.617) that is common in India among returning travellers at Jomo Kenyatta International Airport (JKIA)

Genomic surveillance findings in Kenya: 17th March 2020 to 15th April 2021

Predominance of SARS-CoV-2 Variants of Concern, 501Y.V1 and 501Y.V2 at the Kenyan Coast

Genomic surveillance of SARS-CoV-2 in Kenya

Ongoing genomic surveillance of SARS-CoV-2 in Nairobi and Coastal Kenya

Further detection of SARS-CoV-2 501Y.V1 and 501Y.V2 variants from samples collected in Nairobi and Coastal Kenya

Detection of SARS-CoV-2 501Y.V1 and 501Y. V2 variants of concern in samples collected in Nairobi

Detection of Additional SARS-CoV-2 B.1.351/501Y.V2 Variants and one B.1.1.7/501Y.V1 variants in Kenya

Detection of three additional SARS-CoV-2 501Y. V2 variants at the Kenyan Coast

Detection of SARS-CoV-2 variant 501Y.V2 at Lunga Lunga Border Point, Kwale County

Detection of SARS-CoV-2 Variant 501Y.V1 in Coastal Kenya

Detection of SARS-CoV-2 Variant 501Y.V2 (South African origin) in Coastal Kenya

Genome sequencing of SARS-CoV-2 cases in Kenya

COVID-19 Rapid Response-2020

Reopening schools during the COVID-19 pandemic: A summary of strategies from other countries

Risk factors associated with severe disease and death in COVID-19 patients

Regional Social and Epidemiological Vulnerability to COVID-19 in Kenya

Brief_What are Governments doing in response to the COVID-19 Pandemic

What is the role of testing in the COVID-19 pandemic?

Effectiveness of Face Masks in Preventing Transmission of COVID-19

WHAT CAN WE LEARN COUNTRY EXPERIENCES OF COVID-19 ROLL OUT

How can we strengthen health systems to respond to everyday challenges nancy

Pooled testing for COVID-19 in Kenya

WHAT-ARE-THE-INDIRECT-HEALTH-EFFECTS-OF-THE-COVID-19-PANDEMIC-IN-KENYA

Tackling pandemics quality of care, health workers

A brief history of health worker strikes in Kenya - Nancy

Therapeutic options for the management of COVID-19

Evidence from serological and clinical surveillance and preditive modeling

DFID Policy Brief - Rapid Review of Physical Distancing in Africa - 15MAY2020

COVID-19 Case management costs updated policy brief